NCT04573894View on ClinicalTrials.gov

Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations

CompletedOBSERVATIONAL
Enrollment

147

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

September 5, 2020

Conditions
Blood Culture ContaminationBacteremiaContamination
Interventions
DIAGNOSTIC_TEST

Procalcitonin dosage

Plasma PCT levels measured by automated enzyme immunoassay (Kryptor).

Trial Locations (1)

54500

CHRU of Nancy, Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT04573894 - Diagnostic Performance of Plasma Procalcitonin for the Detection of Blood Cultures Contaminations | Biotech Hunter | Biotech Hunter